BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 27431460)

  • 1. Management and Outcomes in Metaplastic Breast Cancer.
    Tzanninis IG; Kotteas EA; Ntanasis-Stathopoulos I; Kontogianni P; Fotopoulos G
    Clin Breast Cancer; 2016 Dec; 16(6):437-443. PubMed ID: 27431460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged survival of patients with breast cancer-related leptomeningeal metastases.
    Le Rhun E; Taillibert S; Zairi F; Pannier D; Boulanger T; Andre C; Cazin JL; Dubois F; Bonneterre J; Chamberlain MC
    Anticancer Res; 2013 May; 33(5):2057-63. PubMed ID: 23645756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Does obesity modify recurrence-free interval in breast cancer?].
    Kurz C; Obermair A; Schemper W; Kubista E; Sevelda P
    Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():305-7. PubMed ID: 8118326
    [No Abstract]   [Full Text] [Related]  

  • 4. Metaplastic carcinoma of the breast.
    Okada N; Hasebe T; Iwasaki M; Tamura N; Akashi-Tanaka S; Hojo T; Shibata T; Sasajima Y; Kanai Y; Kinoshita T
    Hum Pathol; 2010 Jul; 41(7):960-70. PubMed ID: 20236684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Back to Basics: Traditional Nottingham Grade Mitotic Counts Alone are Significant in Predicting Survival in Invasive Breast Carcinoma.
    Chang JM; McCullough AE; Dueck AC; Kosiorek HE; Ocal IT; Lidner TK; Gray RJ; Wasif N; Northfelt DW; Anderson KS; Pockaj BA
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S509-15. PubMed ID: 26001860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast Cancer in Men: a Report from the Department of Radiation Oncology in Kermanshah Province, Iran.
    Amirifard N; Sadeghi E
    Asian Pac J Cancer Prev; 2016; 17(5):2593-6. PubMed ID: 27268636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of in situ carcinoma of the breast: lobular and ductal origin.
    White RE; Bland KI
    R I Med; 1995 Sep; 78(9):242-5. PubMed ID: 7579718
    [No Abstract]   [Full Text] [Related]  

  • 8. Aurora kinase A as a possible marker for endocrine resistance in early estrogen receptor positive breast cancer.
    Lykkesfeldt AE; Iversen BR; Jensen MB; Ejlertsen B; Giobbie-Hurder A; Reiter BE; Kirkegaard T; Rasmussen BB
    Acta Oncol; 2018 Jan; 57(1):67-73. PubMed ID: 29202611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association with pregnancy increases the risk of local recurrence but does not impact overall survival in breast cancer: A case-control study of 87 cases.
    Genin AS; De Rycke Y; Stevens D; Donnadieu A; Langer A; Rouzier R; Lerebours F
    Breast; 2016 Dec; 30():222-227. PubMed ID: 26456897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Location of Receipt of Initial Treatment and Outcomes in Long-Term Breast Cancer Survivors.
    Sinha AK; Patel JR; Shen Y; Ueno NT; Giordano SH; Tripathy D; Lopez DS; Barcenas CH
    PLoS One; 2017; 12(1):e0170081. PubMed ID: 28085940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metaplastic breast carcinoma: Current therapeutic approaches and novel targeted therapies.
    Drekolias D; Mamounas EP
    Breast J; 2019 Nov; 25(6):1192-1197. PubMed ID: 31250492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distant metastatic breast cancer as an incurable disease: a tenet with a need for revision.
    Güth U; Huang DJ; Dirnhofer S; Rochlitz C; Wight E
    Cancer J; 2009; 15(1):81-6. PubMed ID: 19197181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Observation of an increase in "aggressive tumor forms" in increasing incidence of breast carcinoma].
    Engelhardt C; Sauerland C; Bettges G
    Geburtshilfe Frauenheilkd; 1996 Mar; 56(3):124-7. PubMed ID: 8674957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor characteristics and therapy of elderly patients with breast cancer.
    Grumpelt AM; Ignatov A; Tchaikovski SN; Burger E; Costa SD; Eggemann H
    J Cancer Res Clin Oncol; 2016 May; 142(5):1109-16. PubMed ID: 26809246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in metaplastic carcinoma of the breast: a multi-institutional study.
    Rakha EA; Tan PH; Varga Z; Tse GM; Shaaban AM; Climent F; van Deurzen CH; Purnell D; Dodwell D; Chan T; Ellis IO
    Br J Cancer; 2015 Jan; 112(2):283-9. PubMed ID: 25422911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival outcomes in breast cancer patients with low estrogen/progesterone receptor expression.
    Balduzzi A; Bagnardi V; Rotmensz N; Dellapasqua S; Montagna E; Cardillo A; Viale G; Veronesi P; Intra M; Luini A; Pruneri G; Mastropasqua G; Goldhirsch A; Colleoni M
    Clin Breast Cancer; 2014 Aug; 14(4):258-64. PubMed ID: 24325948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of patients with metastatic breast cancer: a single-centre experience.
    D'hondt R; Spoormans I; Neyens N; Mortier N; Van Aelst F
    Acta Clin Belg; 2014 Jun; 69(3):194-9. PubMed ID: 24641516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ascertaining prognosis for breast cancer in node-negative patients with innovative survival analysis.
    Chapman JA; Lickley HL; Trudeau ME; Hanna WM; Kahn HJ; Murray D; Sawka CA; Mobbs BG; McCready DR; Pritchard KI
    Breast J; 2006; 12(1):37-47. PubMed ID: 16409585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer arising within fibroadenoma: collective analysis of case reports in the literature and hints on treatment policy.
    Wu YT; Chen ST; Chen CJ; Kuo YL; Tseng LM; Chen DR; Kuo SJ; Lai HW
    World J Surg Oncol; 2014 Nov; 12():335. PubMed ID: 25382741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive lobular breast cancer and its variants: how special are they for systemic therapy decisions?
    Guiu S; Wolfer A; Jacot W; Fumoleau P; Romieu G; Bonnetain F; Fiche M
    Crit Rev Oncol Hematol; 2014 Dec; 92(3):235-57. PubMed ID: 25129506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.